As of 2024-12-12, the Relative Valuation of OrganoClick AB (ORGC.ST) is (2.36) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 2.73 SEK, the upside of OrganoClick AB based on Relative Valuation is -186.5%.
The range of the Relative Valuation is (2.39) - (2.58) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 14.4x | 14.0x |
| Forward P/E multiples | 11.1x - 18.5x | 12.4x |
| Fair Price | (2.39) - (2.58) | (2.36) |
| Upside | -187.6% - -194.4% | -186.5% |
| Date | P/E |
| 2024-11-25 | -14.53 |
| 2024-11-22 | -14.87 |
| 2024-11-21 | -14.53 |
| 2024-11-20 | -14.98 |
| 2024-11-19 | -14.98 |
| 2024-11-18 | -14.98 |
| 2024-11-15 | -15.37 |
| 2024-11-14 | -16.27 |
| 2024-11-13 | -15.99 |
| 2024-11-12 | -16.21 |
| 2024-11-11 | -16.10 |
| 2024-11-08 | -16.88 |
| 2024-11-07 | -16.71 |
| 2024-11-06 | -16.21 |
| 2024-11-05 | -16.77 |
| 2024-11-04 | -16.77 |
| 2024-11-01 | -16.54 |
| 2024-10-31 | -16.49 |
| 2024-10-30 | -16.71 |
| 2024-10-29 | -17.27 |
| 2024-10-28 | -16.43 |
| 2024-10-25 | -16.04 |
| 2024-10-24 | -16.10 |
| 2024-10-23 | -16.04 |
| 2024-10-22 | -16.71 |
| 2024-10-21 | -15.99 |
| 2024-10-18 | -15.82 |
| 2024-10-17 | -15.65 |
| 2024-10-16 | -15.65 |
| 2024-10-15 | -16.21 |
| 2024-10-14 | -15.93 |
| 2024-10-11 | -16.21 |
| 2024-10-10 | -16.38 |
| 2024-10-09 | -16.27 |
| 2024-10-08 | -16.66 |
| 2024-10-07 | -16.77 |
| 2024-10-04 | -16.71 |
| 2024-10-03 | -16.54 |
| 2024-10-02 | -16.54 |
| 2024-10-01 | -16.54 |
| 2024-09-30 | -16.60 |
| 2024-09-27 | -16.77 |
| 2024-09-26 | -17.05 |
| 2024-09-25 | -16.94 |
| 2024-09-24 | -17.05 |
| 2024-09-23 | -16.54 |
| 2024-09-20 | -16.66 |
| 2024-09-19 | -16.66 |
| 2024-09-18 | -16.82 |
| 2024-09-17 | -17.10 |